Register entry
- Registered sites
- 2
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Analytical testing2Active ingredient (API) manufacture1Finished drug manufacture1
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Revance Therapeutics, Inc. | Bldg 261 Rm 144 Moffett Blvd, Moffett Field, California (CA) 94035, United States (USA) | Analytical testing | 3019604545118167565 |
| Revance Therapeutics, Inc. | 7555 Gateway Boulevard, Newark, California (CA) 94560, United States (USA) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3007772056118195550 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| DAXXIFY | botulinum toxin type A | injection, powder, lyophilized, for solution, intramuscular | 72960-112BLA |
Compare
Comparable companies in United States
- Deseret Laboratories Incorporated2 sites · 858 NDC
- Padagis Israel Pharmaceuticals Ltd2 sites · 236 NDC
- PureTek Corporation2 sites · 178 NDC
- Cosmax Usa Corporation2 sites · 142 NDC
- Apotheca Company2 sites · 110 NDC
- Nivagen Pharmaceuticals LLC2 sites · 106 NDC
- GOJO Industries, LLC2 sites · 84 NDC
- KVK-TECH, INC.2 sites · 71 NDC
- Revlon Consumer Products Corporation2 sites · 61 NDC
- Samsung Biologics Co., Ltd.2 sites · 57 NDC
Enquiry
Common questions
- Is Revance Therapeutics, Inc. FDA approved?
- Revance Therapeutics, Inc. holds 2 FDA-registered establishments in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Revance Therapeutics, Inc.'s drugs manufactured?
- The FDA register lists Moffett Field, CA; Newark, CA. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.
- What drugs does Revance Therapeutics, Inc. make?
- 1 product is listed under Revance Therapeutics, Inc. in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.